This is in agreement with the data by Paulo et al., who experimentally classified genes differentially expressed in fusion-positive primary prostate tumors into three distinct categories: ERG-targets, ETV1-targets and overlapping targets and showed that TDRD1 belongs to the first category [61]. The gene discussed is TDRD1; the disease is prostate neoplasm.